Results 21 to 30 of about 75,516 (259)
Correction to 'On the Difficulty to Detect Carbapenem Resistance in the Environment: Characterisation of Escherichia coli With Reduced Carbapenem Susceptibility Isolated in a French River'. [PDF]
Environmental Microbiology Reports, Volume 18, Issue 3, June 2026.
europepmc +2 more sources
Carbapenems and febrile neutropenia [PDF]
International ...
Alfandari, S. +2 more
openaire +4 more sources
Carbapenem resistance (CR) is an emerging health issue. Epidemiological surveys on carbapenem-resistant Gram-negative bacilli (CR-GNB) in Lebanon remain scarce.
Mariam Rima +13 more
doaj +1 more source
Carbapenem-Resistant Enterobacteriaceae [PDF]
Carbapenem-resistant Enterobacteriaceae (CRE) have emerged as a major threat. Commonly used antibiotics are generally inactive against CRE. Therefore, timely detection of CRE is of paramount importance. Among CRE, those producing carbapenem-hydrolyzing β-lactamase enzymes (carbapenemase-producing Enterobacteriaceae) are particularly of concern because ...
Alina, Iovleva, Yohei, Doi
openaire +2 more sources
Carbapenem-Resistant Klebsiella pneumoniae Infection and Its Risk Factors in Older Adult Patients
Fatma Çölkesen,1 Arzu Tarakçı,2 Esma Eroğlu,3 Fatma Kacar,4 Şule Özdemir Armağan,2 Selver Can,5 Bağdat Erol,6 Oyagül Aksay,6 Fatih Çölkesen7 1Department of Infectious Diseases and Clinical Microbiology, Konya Numune ...
Çölkesen F +8 more
doaj
The effectiveness of piperacillin/tazobactam for managing nosocomial pneumonia caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae is unknown.
Lei Zha +8 more
doaj +1 more source
Gram-negative bacteria belonging to the Enterobacter cloacae complex are increasingly implicated in difficult-to-treat nosocomial infections, as exemplified by a recently characterized highly carbapenem-resistant clinical Enterobacter roggenkampii ...
Suruchi Nepal +7 more
doaj +1 more source
Pharmacokinetics of Meropenem in People with Cystic Fibrosis—A Proof of Concept Clinical Trial
Anti-infective treatment of pulmonary exacerbations is a major issue in people with cystic fibrosis (CF). Individualized dosing strategies and adaptation of infusion times are important concepts to optimize anti-infective therapy. In this prospective non-
Jan C. Kamp +8 more
doaj +1 more source
Acinetobacter baumannii is a Gram-negative coccobacillus responsible for severe hospital-acquired infections, particularly in intensive care units (ICUs).
Mahmoud A. F. Khalil +12 more
doaj +1 more source
Carbapenem-resistance and pathogenicity of bovine Acinetobacter indicus-like isolates [PDF]
The objective of this study was to characterize blaOXA-23 harbouring Acinetobacter indicus-like strains from cattle including genomic and phylogenetic analyses, antimicrobial susceptibility testing and evaluation of pathogenicity in vitro and in vivo ...
Torsten Semmler +17 more
core +1 more source

